NCT04800237 - Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety | Biotech Hunter

Enrollment

230

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

August 2, 2022

Study Completion Date

August 2, 2022

Conditions

Performance Anxiety

Interventions

DRUG

VQW-765

oral capsule

DRUG

Placebo

oral capsule

Trial Locations (15)

10016

Vanda Investigational Site, New York

10312

Vanda Investigational Site, Staten Island

27612

Vanda Investigational Site, Raleigh

32816

Vanda Investigational Site, Orlando

45212

Vanda Investigational Site, Cincinnati

77074

Vanda Investigational Site, Houston

85281

Vanda Investigational Site, Tempe

89119

Vanda Investigational Site, Las Vegas

90212

Vanda Investigational Site, Beverly Hills

90502

Vanda Investigational Site, Torrance

92845

Vanda Investigational Site, Garden Grove

95124

Vanda Investigational Site, San Jose

02114

Vanda Investigational Site, Boston

02747

Vanda Investigational Site, North Dartmouth

08009

Vanda Investigational Site, Berlin